Search

everythinglearnresearchcommunity

for

Search:↓

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

People with alopecia who are more resilient tend to feel less stressed.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Hair loss greatly lowers perceived health in both genders, and hair transplant surgery notably improves this.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Inositol was not more effective than a placebo in treating trichotillomania.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.